insights_auto
Why is ROIV down 2.76%?
Dive Deeperchevron_right
ROIV:NASDAQ
Roivant Sciences Ltd
$35.89
arrow_downward
-2.76%(-1.02) 1D
$35.89
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 2, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ROIV...
Open
$36.95
High
$37.29
Low
$35.81
Mkt. cap
25.92B
Avg. vol.
6.47M
Volume
5.70M
52-wk high
$42.50
52-wk low
$19.30
EPS
-$0.39
Beta
1.10
Shares outstanding
722.32M
No. of employees
721
Open
$36.95
High
$37.29
Low
$35.81
Mkt. cap
25.92B
Avg. vol.
6.47M
Volume
5.70M
52-wk high
$42.50
52-wk low
$19.30
EPS
-$0.39
Beta
1.10
Shares outstanding
722.32M
No. of employees
721
News stories
From web sources and news partners
Seeking Alpha
·
14 minutes ago
Nasdaq And S&P 500 Index Lose Momentum, Pull Down Market
www.foreignpolicyjournal.com
·
25 minutes ago
Billions In Cash Burn Separate IREN And Applied Digital (NASDAQ: APLD) As AI Infrastructure Race Heats Up
GreenevilleSun.com
·
17 minutes ago
More drops for AI and tech stocks overshadow gains for most of Wall Street
Bloomberg.com
·
12 minutes ago
Nasdaq Slide Clouds Asian Open, Oil Falls on Iran: Markets Wrap
Profile
Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel. Wikipedia
About Roivant Sciences Ltd